The NM_000203.5(IDUA):c.236C>T variant in IDUA is a missense variant predicted to cause substitution of Alanine by Valine at amino acid 79 (p.Ala79Val). At least 1 patient with this variant had documented IDUA deficiency within the affected range in leukocytes, urinary GAGs elevation above normal range, and clinical features specific to MPS I including hepatosplenomegaly, arthropathy, and corneal involvement (PP4). This variant has been detected in at least 11 individuals with MPS I. Of those individuals, 2 were compound heterozygous, phase not confirmed, for the variant and a variant in IDUA that has been classified as likely pathogenic by the ClinGen LD VCEP (variants: c.1882C>T (p.Arg628Ter) (ClinVar Variation ID: 550421), and c.1402+1G>T) (ClinVar Variation ID: 1323099) (2 x 0.25 points = 0.5 points). Another six individuals are compound heterozygous for the variant and a variant in IDUA, either c.536C>G (p.Thr179Arg) (ClinVar Variation ID: 556358), c.589G>A ((p.Val197Ile) (ClinVar Variation ID: 2720835), c.265C>T (p.Arg89Trp) (ClinVar Variation ID: 580286), c.1877G>A (p.Trp626Ter) (ClinVar Variation ID: 928997), or c.1037T>G (p.Leu346Arg) (ClinVar Variation ID: 11927) (PMIDs: 27520059, 21480867). The allelic data from these individuals will be used in the assessment of the second variant. Three individuals were homozygous for the variant (1 point; PMID: 21480867) (PM3). Total 1.5 points (PM3) This variant is absent in gnomAD v4.1.0 (PM2_Supporting). Expression of the variant in CHO-cells resulted in less than 0.1% wild type IDUA activity indicating that this variant may impact protein function (PMID:15300847)(PS3_Supporting). The computational predictor REVEL gives a score of 0.738 which is in the range 0.644-0.773, evidence that correlates with impact to IDUA function at the supporting level (Pejaver et al.) (PP3). Another missense variant c.235G>A (p.Ala79Thr) in the same codon has not yet been reported in a patient with MPS I. Additionally, this other variant has not yet met the criteria to be classified as pathogenic or likely pathogenic by the ClinGen LD VCEP (PM5 not met). There is a ClinVar entry for this variant (Variation ID: 1458769). In summary, this variant meets the criteria to be classified as likely pathogenic for MPS I based on the ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert panel (Specifications Version 1.0.0): PP4, PM3, PM2_Supporting, PS3_Supporting, PP3 (Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on December 6, 2024)